Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IP Cisplatin/Carboplatin and Floxuridine for Ovarian and GI Cancers
NCT00005049Phase 2Completed
- Sponsor
- NYU Langone Health
- Start
- May 1997
- Primary completion
- Nov 2006
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of floxuridine, cisplatin, carboplatin in ovarian cancer, gastrointestinal cancer, sponsored by NYU Langone Health. Started May 1997; status: completed.
02
Drugs
floxuridinecisplatincarboplatin
03
Conditions
ovarian cancergastrointestinal cancer
Beyond the preview
Go deeper on NCT00005049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005049.